WebJul 23, 2024 · Changchun Changsheng’s parent company, Shenzhen-listed Changsheng Biotechnology, has made a public apology and voluntarily recalled all their rabies vaccines available on the market, staet media reported. The company stated the recall would cost over 200 million yuan, CGTN reports. WebJul 24, 2024 · Under pressure, Changsheng has recalled its vaccine for rabies and been fined for selling ineffective vaccines to inoculate children against diphtheria, whooping …
Chinese social media suggest decreased vaccine acceptance in
WebJul 22, 2024 · Chinese police have launched an investigation into Changsheng Biotechnology Co, its chairwoman and four senior executives over suspected criminal behavior, the official Xinhua news agency said ... WebJan 28, 2024 · Changsheng Biotechnology, the second largest producer of rabies vaccines was punished by the regulator for falsifying production data in late July last year. It was ordered to delist from the Shenzhen Stock Exchange this month. the initial process
Biosynthetic Diversification of Fidaxomicin Aglycones by …
WebChangsheng Bio Technology Co male healthy icr mice Male Healthy Icr Mice, supplied by Changsheng Bio Technology Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and … WebNov 3, 2024 · The Changchun Changsheng Biotechnology Company was found to have violated good manufacturing practices in July 2024, leading to widespread distribution of … WebApr 10, 2024 · From April 2024 to present, Ms. Wang serves as the director of China Ruiyuan Holdings Co., Ltd (Hong Kong) and the director of Anhui Zhongruiyuan Biotechnology Co., Ltd. Ms. Wang graduated with a bachelor’s degree from West Anhui University in 2004. Mr. Changsheng Zheng has been serving as our CFO since April … the initial purpose